PVA and alginate nanofibers can modulate obesity, reduce blood glucose levels, and reduce serum levels of insulin, ALT, ALP, GGT, creatinine, TNF-α, and IL-1β in diabetic rats. This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.